nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—ACE—stomach cancer	0.226	0.709	CbGaD
Losartan—ALB—stomach cancer	0.0928	0.291	CbGaD
Losartan—UGT2B7—Epirubicin—stomach cancer	0.0534	0.131	CbGbCtD
Losartan—UGT1A1—Irinotecan—stomach cancer	0.0449	0.11	CbGbCtD
Losartan—SLCO1B3—Docetaxel—stomach cancer	0.0391	0.0959	CbGbCtD
Losartan—ABCB1—Mitomycin—stomach cancer	0.0347	0.0851	CbGbCtD
Losartan—SLCO1B1—Irinotecan—stomach cancer	0.0311	0.0762	CbGbCtD
Losartan—SLCO1B3—Methotrexate—stomach cancer	0.0282	0.0693	CbGbCtD
Losartan—ALB—Irinotecan—stomach cancer	0.017	0.0417	CbGbCtD
Losartan—SLCO1B1—Methotrexate—stomach cancer	0.0164	0.0403	CbGbCtD
Losartan—ALB—Fluorouracil—stomach cancer	0.0163	0.0401	CbGbCtD
Losartan—CYP2C9—Capecitabine—stomach cancer	0.0148	0.0364	CbGbCtD
Losartan—CYP3A5—Irinotecan—stomach cancer	0.0137	0.0336	CbGbCtD
Losartan—CYP2C8—Fluorouracil—stomach cancer	0.0126	0.031	CbGbCtD
Losartan—SLC22A6—Methotrexate—stomach cancer	0.0106	0.0259	CbGbCtD
Losartan—CYP3A5—Docetaxel—stomach cancer	0.01	0.0246	CbGbCtD
Losartan—CYP1A2—Fluorouracil—stomach cancer	0.00977	0.024	CbGbCtD
Losartan—ALB—Methotrexate—stomach cancer	0.00901	0.0221	CbGbCtD
Losartan—ABCB1—Irinotecan—stomach cancer	0.0089	0.0218	CbGbCtD
Losartan—CYP2C9—Fluorouracil—stomach cancer	0.0088	0.0216	CbGbCtD
Losartan—ABCB1—Docetaxel—stomach cancer	0.00652	0.016	CbGbCtD
Losartan—CYP3A4—Irinotecan—stomach cancer	0.00533	0.0131	CbGbCtD
Losartan—ABCB1—Doxorubicin—stomach cancer	0.00486	0.0119	CbGbCtD
Losartan—UGT2B17—epithelium—stomach cancer	0.00474	0.0743	CbGeAlD
Losartan—ABCB1—Methotrexate—stomach cancer	0.00471	0.0116	CbGbCtD
Losartan—CYP3A4—Docetaxel—stomach cancer	0.00391	0.00959	CbGbCtD
Losartan—ACE—vein—stomach cancer	0.00384	0.0602	CbGeAlD
Losartan—UGT2B17—digestive system—stomach cancer	0.00361	0.0565	CbGeAlD
Losartan—UGT2B17—endocrine gland—stomach cancer	0.00298	0.0467	CbGeAlD
Losartan—CYP3A4—Doxorubicin—stomach cancer	0.00291	0.00715	CbGbCtD
Losartan—Tasosartan—AGTR2—stomach cancer	0.00278	0.619	CrCbGaD
Losartan—UGT2B17—liver—stomach cancer	0.00269	0.0421	CbGeAlD
Losartan—SLC22A12—digestive system—stomach cancer	0.00232	0.0364	CbGeAlD
Losartan—UGT1A10—digestive system—stomach cancer	0.00204	0.0319	CbGeAlD
Losartan—UGT1A10—endocrine gland—stomach cancer	0.00168	0.0264	CbGeAlD
Losartan—AGTR1—blood vessel—stomach cancer	0.00165	0.0259	CbGeAlD
Losartan—UGT1A10—liver—stomach cancer	0.00152	0.0238	CbGeAlD
Losartan—UGT1A3—digestive system—stomach cancer	0.00144	0.0225	CbGeAlD
Losartan—SLC2A9—endocrine gland—stomach cancer	0.00132	0.0207	CbGeAlD
Losartan—ACE—blood vessel—stomach cancer	0.00122	0.0191	CbGeAlD
Losartan—ALB—gall bladder—stomach cancer	0.0012	0.0188	CbGeAlD
Losartan—SLC2A9—liver—stomach cancer	0.00119	0.0186	CbGeAlD
Losartan—UGT1A3—endocrine gland—stomach cancer	0.00119	0.0186	CbGeAlD
Losartan—UGT1A3—liver—stomach cancer	0.00107	0.0168	CbGeAlD
Losartan—Irbesartan—JUN—stomach cancer	0.00102	0.227	CrCbGaD
Losartan—UGT1A1—hematopoietic system—stomach cancer	0.00101	0.0158	CbGeAlD
Losartan—SLC2A9—lymph node—stomach cancer	0.000912	0.0143	CbGeAlD
Losartan—AGTR1—hematopoietic system—stomach cancer	0.00088	0.0138	CbGeAlD
Losartan—SLCO1B1—hematopoietic system—stomach cancer	0.000839	0.0131	CbGeAlD
Losartan—SLCO1B3—endocrine gland—stomach cancer	0.000833	0.0131	CbGeAlD
Losartan—UGT2B7—digestive system—stomach cancer	0.000825	0.0129	CbGeAlD
Losartan—AGTR1—epithelium—stomach cancer	0.000804	0.0126	CbGeAlD
Losartan—AGTR1—smooth muscle tissue—stomach cancer	0.000775	0.0121	CbGeAlD
Losartan—SLCO1B3—liver—stomach cancer	0.000751	0.0118	CbGeAlD
Losartan—UGT1A1—digestive system—stomach cancer	0.000701	0.011	CbGeAlD
Losartan—UGT2B7—endocrine gland—stomach cancer	0.000681	0.0107	CbGeAlD
Losartan—ACE—hematopoietic system—stomach cancer	0.00065	0.0102	CbGeAlD
Losartan—AGTR1—lymphoid tissue—stomach cancer	0.000619	0.0097	CbGeAlD
Losartan—UGT2B7—liver—stomach cancer	0.000614	0.00962	CbGeAlD
Losartan—ACE—epithelium—stomach cancer	0.000594	0.0093	CbGeAlD
Losartan—SLCO1B1—digestive system—stomach cancer	0.000583	0.00914	CbGeAlD
Losartan—UGT1A1—endocrine gland—stomach cancer	0.000579	0.00908	CbGeAlD
Losartan—ACE—smooth muscle tissue—stomach cancer	0.000572	0.00896	CbGeAlD
Losartan—CYP2C19—hematopoietic system—stomach cancer	0.000546	0.00856	CbGeAlD
Losartan—UGT1A1—liver—stomach cancer	0.000522	0.00818	CbGeAlD
Losartan—AGTR1—endocrine gland—stomach cancer	0.000506	0.00792	CbGeAlD
Losartan—Telmisartan—PPARG—stomach cancer	0.000494	0.11	CrCbGaD
Losartan—SLCO1B1—endocrine gland—stomach cancer	0.000482	0.00755	CbGeAlD
Losartan—CYP2C8—hematopoietic system—stomach cancer	0.000477	0.00747	CbGeAlD
Losartan—ACE—lymphoid tissue—stomach cancer	0.000457	0.00716	CbGeAlD
Losartan—AGTR1—liver—stomach cancer	0.000456	0.00714	CbGeAlD
Losartan—ACE—digestive system—stomach cancer	0.000452	0.00708	CbGeAlD
Losartan—CYP1A2—hematopoietic system—stomach cancer	0.000446	0.00699	CbGeAlD
Losartan—SLCO1B1—liver—stomach cancer	0.000435	0.00681	CbGeAlD
Losartan—CYP3A5—hematopoietic system—stomach cancer	0.00043	0.00674	CbGeAlD
Losartan—ABCB1—blood vessel—stomach cancer	0.000429	0.00673	CbGeAlD
Losartan—CYP2C9—hematopoietic system—stomach cancer	0.000424	0.00664	CbGeAlD
Losartan—ACE—bone marrow—stomach cancer	0.000416	0.00652	CbGeAlD
Losartan—CYP2C19—digestive system—stomach cancer	0.00038	0.00595	CbGeAlD
Losartan—ACE—endocrine gland—stomach cancer	0.000373	0.00585	CbGeAlD
Losartan—ALB—liver—stomach cancer	0.000352	0.00551	CbGeAlD
Losartan—CYP3A5—pancreas—stomach cancer	0.000351	0.00549	CbGeAlD
Losartan—AGTR1—lymph node—stomach cancer	0.000349	0.00547	CbGeAlD
Losartan—ACE—liver—stomach cancer	0.000337	0.00527	CbGeAlD
Losartan—CYP3A4—hematopoietic system—stomach cancer	0.000323	0.00506	CbGeAlD
Losartan—CYP2C19—endocrine gland—stomach cancer	0.000314	0.00492	CbGeAlD
Losartan—CYP1A2—digestive system—stomach cancer	0.00031	0.00486	CbGeAlD
Losartan—CYP3A5—digestive system—stomach cancer	0.000299	0.00469	CbGeAlD
Losartan—CYP2C9—digestive system—stomach cancer	0.000295	0.00462	CbGeAlD
Losartan—CYP2C19—liver—stomach cancer	0.000283	0.00444	CbGeAlD
Losartan—CYP2C8—endocrine gland—stomach cancer	0.000274	0.00429	CbGeAlD
Losartan—ALB—lymph node—stomach cancer	0.00027	0.00422	CbGeAlD
Losartan—ACE—lymph node—stomach cancer	0.000258	0.00404	CbGeAlD
Losartan—CYP1A2—endocrine gland—stomach cancer	0.000256	0.00402	CbGeAlD
Losartan—CYP3A5—endocrine gland—stomach cancer	0.000247	0.00388	CbGeAlD
Losartan—CYP2C8—liver—stomach cancer	0.000247	0.00387	CbGeAlD
Losartan—CYP2C9—endocrine gland—stomach cancer	0.000243	0.00381	CbGeAlD
Losartan—CYP1A2—liver—stomach cancer	0.000231	0.00362	CbGeAlD
Losartan—ABCB1—hematopoietic system—stomach cancer	0.000229	0.00358	CbGeAlD
Losartan—CYP3A4—digestive system—stomach cancer	0.000225	0.00352	CbGeAlD
Losartan—CYP3A5—liver—stomach cancer	0.000223	0.00349	CbGeAlD
Losartan—CYP2C9—liver—stomach cancer	0.00022	0.00344	CbGeAlD
Losartan—ABCB1—epithelium—stomach cancer	0.000209	0.00327	CbGeAlD
Losartan—Valsartan—ALB—stomach cancer	0.000198	0.044	CrCbGaD
Losartan—ABCB1—pancreas—stomach cancer	0.000186	0.00292	CbGeAlD
Losartan—CYP3A4—endocrine gland—stomach cancer	0.000186	0.00291	CbGeAlD
Losartan—CYP3A4—liver—stomach cancer	0.000167	0.00262	CbGeAlD
Losartan—ABCB1—lymphoid tissue—stomach cancer	0.000161	0.00252	CbGeAlD
Losartan—ABCB1—digestive system—stomach cancer	0.000159	0.00249	CbGeAlD
Losartan—ABCB1—bone marrow—stomach cancer	0.000147	0.0023	CbGeAlD
Losartan—ABCB1—endocrine gland—stomach cancer	0.000131	0.00206	CbGeAlD
Losartan—ABCB1—liver—stomach cancer	0.000118	0.00186	CbGeAlD
Losartan—Hyperhidrosis—Capecitabine—stomach cancer	9.17e-05	0.000701	CcSEcCtD
Losartan—Hypotension—Docetaxel—stomach cancer	9.15e-05	0.0007	CcSEcCtD
Losartan—ABCB1—lymph node—stomach cancer	9.08e-05	0.00142	CbGeAlD
Losartan—Epistaxis—Doxorubicin—stomach cancer	9.04e-05	0.000692	CcSEcCtD
Losartan—Anorexia—Capecitabine—stomach cancer	9.04e-05	0.000692	CcSEcCtD
Losartan—Angiopathy—Methotrexate—stomach cancer	9.01e-05	0.00069	CcSEcCtD
Losartan—Vomiting—Irinotecan—stomach cancer	9.01e-05	0.000689	CcSEcCtD
Losartan—Sinusitis—Doxorubicin—stomach cancer	8.99e-05	0.000688	CcSEcCtD
Losartan—Dizziness—Fluorouracil—stomach cancer	8.97e-05	0.000687	CcSEcCtD
Losartan—Agranulocytosis—Doxorubicin—stomach cancer	8.94e-05	0.000684	CcSEcCtD
Losartan—Rash—Irinotecan—stomach cancer	8.93e-05	0.000684	CcSEcCtD
Losartan—Dermatitis—Irinotecan—stomach cancer	8.93e-05	0.000683	CcSEcCtD
Losartan—Musculoskeletal discomfort—Docetaxel—stomach cancer	8.92e-05	0.000683	CcSEcCtD
Losartan—Headache—Irinotecan—stomach cancer	8.88e-05	0.000679	CcSEcCtD
Losartan—Hypotension—Capecitabine—stomach cancer	8.86e-05	0.000678	CcSEcCtD
Losartan—Insomnia—Docetaxel—stomach cancer	8.86e-05	0.000678	CcSEcCtD
Losartan—Paraesthesia—Docetaxel—stomach cancer	8.79e-05	0.000673	CcSEcCtD
Losartan—Erythema multiforme—Epirubicin—stomach cancer	8.79e-05	0.000673	CcSEcCtD
Losartan—Alopecia—Methotrexate—stomach cancer	8.78e-05	0.000672	CcSEcCtD
Losartan—Dyspnoea—Docetaxel—stomach cancer	8.73e-05	0.000668	CcSEcCtD
Losartan—Somnolence—Docetaxel—stomach cancer	8.71e-05	0.000666	CcSEcCtD
Losartan—Tinnitus—Epirubicin—stomach cancer	8.67e-05	0.000663	CcSEcCtD
Losartan—Erythema—Methotrexate—stomach cancer	8.65e-05	0.000662	CcSEcCtD
Losartan—Musculoskeletal discomfort—Capecitabine—stomach cancer	8.64e-05	0.000661	CcSEcCtD
Losartan—Flushing—Epirubicin—stomach cancer	8.63e-05	0.00066	CcSEcCtD
Losartan—Vomiting—Fluorouracil—stomach cancer	8.63e-05	0.00066	CcSEcCtD
Losartan—Rhinitis—Doxorubicin—stomach cancer	8.63e-05	0.00066	CcSEcCtD
Losartan—Dyspepsia—Docetaxel—stomach cancer	8.62e-05	0.00066	CcSEcCtD
Losartan—Hepatitis—Doxorubicin—stomach cancer	8.6e-05	0.000658	CcSEcCtD
Losartan—Insomnia—Capecitabine—stomach cancer	8.58e-05	0.000656	CcSEcCtD
Losartan—Hypoaesthesia—Doxorubicin—stomach cancer	8.56e-05	0.000655	CcSEcCtD
Losartan—Rash—Fluorouracil—stomach cancer	8.56e-05	0.000655	CcSEcCtD
Losartan—Dermatitis—Fluorouracil—stomach cancer	8.55e-05	0.000654	CcSEcCtD
Losartan—Pharyngitis—Doxorubicin—stomach cancer	8.54e-05	0.000653	CcSEcCtD
Losartan—Paraesthesia—Capecitabine—stomach cancer	8.51e-05	0.000652	CcSEcCtD
Losartan—Decreased appetite—Docetaxel—stomach cancer	8.51e-05	0.000651	CcSEcCtD
Losartan—Headache—Fluorouracil—stomach cancer	8.5e-05	0.000651	CcSEcCtD
Losartan—Dysgeusia—Methotrexate—stomach cancer	8.47e-05	0.000648	CcSEcCtD
Losartan—Dyspnoea—Capecitabine—stomach cancer	8.45e-05	0.000647	CcSEcCtD
Losartan—Fatigue—Docetaxel—stomach cancer	8.44e-05	0.000646	CcSEcCtD
Losartan—Angiopathy—Epirubicin—stomach cancer	8.44e-05	0.000646	CcSEcCtD
Losartan—Nausea—Irinotecan—stomach cancer	8.42e-05	0.000644	CcSEcCtD
Losartan—Constipation—Docetaxel—stomach cancer	8.38e-05	0.000641	CcSEcCtD
Losartan—Pain—Docetaxel—stomach cancer	8.38e-05	0.000641	CcSEcCtD
Losartan—Back pain—Methotrexate—stomach cancer	8.37e-05	0.00064	CcSEcCtD
Losartan—Dyspepsia—Capecitabine—stomach cancer	8.35e-05	0.000639	CcSEcCtD
Losartan—Arrhythmia—Epirubicin—stomach cancer	8.31e-05	0.000636	CcSEcCtD
Losartan—Decreased appetite—Capecitabine—stomach cancer	8.24e-05	0.000631	CcSEcCtD
Losartan—Alopecia—Epirubicin—stomach cancer	8.22e-05	0.000629	CcSEcCtD
Losartan—Fatigue—Capecitabine—stomach cancer	8.18e-05	0.000626	CcSEcCtD
Losartan—Vision blurred—Methotrexate—stomach cancer	8.15e-05	0.000624	CcSEcCtD
Losartan—Erythema multiforme—Doxorubicin—stomach cancer	8.13e-05	0.000622	CcSEcCtD
Losartan—Pain—Capecitabine—stomach cancer	8.11e-05	0.000621	CcSEcCtD
Losartan—Constipation—Capecitabine—stomach cancer	8.11e-05	0.000621	CcSEcCtD
Losartan—Erythema—Epirubicin—stomach cancer	8.09e-05	0.000619	CcSEcCtD
Losartan—Feeling abnormal—Docetaxel—stomach cancer	8.07e-05	0.000618	CcSEcCtD
Losartan—Nausea—Fluorouracil—stomach cancer	8.06e-05	0.000617	CcSEcCtD
Losartan—Ill-defined disorder—Methotrexate—stomach cancer	8.03e-05	0.000614	CcSEcCtD
Losartan—Tinnitus—Doxorubicin—stomach cancer	8.02e-05	0.000614	CcSEcCtD
Losartan—Gastrointestinal pain—Docetaxel—stomach cancer	8.01e-05	0.000613	CcSEcCtD
Losartan—Anaemia—Methotrexate—stomach cancer	7.99e-05	0.000612	CcSEcCtD
Losartan—Flushing—Doxorubicin—stomach cancer	7.98e-05	0.000611	CcSEcCtD
Losartan—Flatulence—Epirubicin—stomach cancer	7.98e-05	0.00061	CcSEcCtD
Losartan—Tension—Epirubicin—stomach cancer	7.94e-05	0.000608	CcSEcCtD
Losartan—Dysgeusia—Epirubicin—stomach cancer	7.93e-05	0.000607	CcSEcCtD
Losartan—Nervousness—Epirubicin—stomach cancer	7.86e-05	0.000602	CcSEcCtD
Losartan—Back pain—Epirubicin—stomach cancer	7.83e-05	0.000599	CcSEcCtD
Losartan—Feeling abnormal—Capecitabine—stomach cancer	7.81e-05	0.000598	CcSEcCtD
Losartan—Angiopathy—Doxorubicin—stomach cancer	7.81e-05	0.000597	CcSEcCtD
Losartan—Malaise—Methotrexate—stomach cancer	7.8e-05	0.000597	CcSEcCtD
Losartan—Muscle spasms—Epirubicin—stomach cancer	7.78e-05	0.000595	CcSEcCtD
Losartan—Vertigo—Methotrexate—stomach cancer	7.77e-05	0.000595	CcSEcCtD
Losartan—Gastrointestinal pain—Capecitabine—stomach cancer	7.75e-05	0.000593	CcSEcCtD
Losartan—Abdominal pain—Docetaxel—stomach cancer	7.74e-05	0.000592	CcSEcCtD
Losartan—Body temperature increased—Docetaxel—stomach cancer	7.74e-05	0.000592	CcSEcCtD
Losartan—Leukopenia—Methotrexate—stomach cancer	7.74e-05	0.000592	CcSEcCtD
Losartan—Arrhythmia—Doxorubicin—stomach cancer	7.69e-05	0.000588	CcSEcCtD
Losartan—Vision blurred—Epirubicin—stomach cancer	7.63e-05	0.000584	CcSEcCtD
Losartan—Alopecia—Doxorubicin—stomach cancer	7.6e-05	0.000582	CcSEcCtD
Losartan—Cough—Methotrexate—stomach cancer	7.55e-05	0.000578	CcSEcCtD
Losartan—Urticaria—Capecitabine—stomach cancer	7.53e-05	0.000576	CcSEcCtD
Losartan—Ill-defined disorder—Epirubicin—stomach cancer	7.51e-05	0.000575	CcSEcCtD
Losartan—Body temperature increased—Capecitabine—stomach cancer	7.5e-05	0.000574	CcSEcCtD
Losartan—Abdominal pain—Capecitabine—stomach cancer	7.5e-05	0.000574	CcSEcCtD
Losartan—Erythema—Doxorubicin—stomach cancer	7.49e-05	0.000573	CcSEcCtD
Losartan—Anaemia—Epirubicin—stomach cancer	7.48e-05	0.000572	CcSEcCtD
Losartan—Agitation—Epirubicin—stomach cancer	7.44e-05	0.000569	CcSEcCtD
Losartan—Flatulence—Doxorubicin—stomach cancer	7.38e-05	0.000565	CcSEcCtD
Losartan—Myalgia—Methotrexate—stomach cancer	7.36e-05	0.000563	CcSEcCtD
Losartan—Arthralgia—Methotrexate—stomach cancer	7.36e-05	0.000563	CcSEcCtD
Losartan—Chest pain—Methotrexate—stomach cancer	7.36e-05	0.000563	CcSEcCtD
Losartan—Tension—Doxorubicin—stomach cancer	7.35e-05	0.000562	CcSEcCtD
Losartan—Dysgeusia—Doxorubicin—stomach cancer	7.33e-05	0.000561	CcSEcCtD
Losartan—Malaise—Epirubicin—stomach cancer	7.3e-05	0.000559	CcSEcCtD
Losartan—Discomfort—Methotrexate—stomach cancer	7.28e-05	0.000557	CcSEcCtD
Losartan—Nervousness—Doxorubicin—stomach cancer	7.27e-05	0.000557	CcSEcCtD
Losartan—Vertigo—Epirubicin—stomach cancer	7.27e-05	0.000556	CcSEcCtD
Losartan—Syncope—Epirubicin—stomach cancer	7.26e-05	0.000555	CcSEcCtD
Losartan—Leukopenia—Epirubicin—stomach cancer	7.25e-05	0.000554	CcSEcCtD
Losartan—Back pain—Doxorubicin—stomach cancer	7.24e-05	0.000554	CcSEcCtD
Losartan—Hypersensitivity—Docetaxel—stomach cancer	7.22e-05	0.000552	CcSEcCtD
Losartan—Muscle spasms—Doxorubicin—stomach cancer	7.2e-05	0.000551	CcSEcCtD
Losartan—Palpitations—Epirubicin—stomach cancer	7.15e-05	0.000547	CcSEcCtD
Losartan—Confusional state—Methotrexate—stomach cancer	7.12e-05	0.000545	CcSEcCtD
Losartan—Loss of consciousness—Epirubicin—stomach cancer	7.11e-05	0.000544	CcSEcCtD
Losartan—Cough—Epirubicin—stomach cancer	7.06e-05	0.00054	CcSEcCtD
Losartan—Anaphylactic shock—Methotrexate—stomach cancer	7.06e-05	0.00054	CcSEcCtD
Losartan—Vision blurred—Doxorubicin—stomach cancer	7.06e-05	0.00054	CcSEcCtD
Losartan—Asthenia—Docetaxel—stomach cancer	7.03e-05	0.000538	CcSEcCtD
Losartan—Infection—Methotrexate—stomach cancer	7.01e-05	0.000537	CcSEcCtD
Losartan—Hypersensitivity—Capecitabine—stomach cancer	6.99e-05	0.000535	CcSEcCtD
Losartan—Ill-defined disorder—Doxorubicin—stomach cancer	6.95e-05	0.000532	CcSEcCtD
Losartan—Pruritus—Docetaxel—stomach cancer	6.93e-05	0.00053	CcSEcCtD
Losartan—Nervous system disorder—Methotrexate—stomach cancer	6.92e-05	0.00053	CcSEcCtD
Losartan—Anaemia—Doxorubicin—stomach cancer	6.92e-05	0.00053	CcSEcCtD
Losartan—Thrombocytopenia—Methotrexate—stomach cancer	6.91e-05	0.000529	CcSEcCtD
Losartan—Myalgia—Epirubicin—stomach cancer	6.89e-05	0.000527	CcSEcCtD
Losartan—Chest pain—Epirubicin—stomach cancer	6.89e-05	0.000527	CcSEcCtD
Losartan—Arthralgia—Epirubicin—stomach cancer	6.89e-05	0.000527	CcSEcCtD
Losartan—Agitation—Doxorubicin—stomach cancer	6.88e-05	0.000527	CcSEcCtD
Losartan—Anxiety—Epirubicin—stomach cancer	6.87e-05	0.000525	CcSEcCtD
Losartan—Hyperhidrosis—Methotrexate—stomach cancer	6.82e-05	0.000522	CcSEcCtD
Losartan—Discomfort—Epirubicin—stomach cancer	6.81e-05	0.000521	CcSEcCtD
Losartan—Asthenia—Capecitabine—stomach cancer	6.8e-05	0.000521	CcSEcCtD
Losartan—Malaise—Doxorubicin—stomach cancer	6.75e-05	0.000517	CcSEcCtD
Losartan—Dry mouth—Epirubicin—stomach cancer	6.74e-05	0.000516	CcSEcCtD
Losartan—Vertigo—Doxorubicin—stomach cancer	6.73e-05	0.000515	CcSEcCtD
Losartan—Anorexia—Methotrexate—stomach cancer	6.73e-05	0.000515	CcSEcCtD
Losartan—Syncope—Doxorubicin—stomach cancer	6.72e-05	0.000514	CcSEcCtD
Losartan—Pruritus—Capecitabine—stomach cancer	6.71e-05	0.000513	CcSEcCtD
Losartan—Leukopenia—Doxorubicin—stomach cancer	6.7e-05	0.000513	CcSEcCtD
Losartan—Diarrhoea—Docetaxel—stomach cancer	6.7e-05	0.000513	CcSEcCtD
Losartan—Confusional state—Epirubicin—stomach cancer	6.66e-05	0.00051	CcSEcCtD
Losartan—Palpitations—Doxorubicin—stomach cancer	6.62e-05	0.000506	CcSEcCtD
Losartan—Oedema—Epirubicin—stomach cancer	6.61e-05	0.000506	CcSEcCtD
Losartan—Anaphylactic shock—Epirubicin—stomach cancer	6.61e-05	0.000506	CcSEcCtD
Losartan—Hypotension—Methotrexate—stomach cancer	6.6e-05	0.000505	CcSEcCtD
Losartan—Loss of consciousness—Doxorubicin—stomach cancer	6.58e-05	0.000504	CcSEcCtD
Losartan—Infection—Epirubicin—stomach cancer	6.56e-05	0.000502	CcSEcCtD
Losartan—Cough—Doxorubicin—stomach cancer	6.54e-05	0.0005	CcSEcCtD
Losartan—Shock—Epirubicin—stomach cancer	6.5e-05	0.000497	CcSEcCtD
Losartan—Diarrhoea—Capecitabine—stomach cancer	6.49e-05	0.000496	CcSEcCtD
Losartan—Nervous system disorder—Epirubicin—stomach cancer	6.48e-05	0.000496	CcSEcCtD
Losartan—Dizziness—Docetaxel—stomach cancer	6.48e-05	0.000496	CcSEcCtD
Losartan—Thrombocytopenia—Epirubicin—stomach cancer	6.47e-05	0.000495	CcSEcCtD
Losartan—Tachycardia—Epirubicin—stomach cancer	6.45e-05	0.000493	CcSEcCtD
Losartan—Musculoskeletal discomfort—Methotrexate—stomach cancer	6.43e-05	0.000492	CcSEcCtD
Losartan—Hyperhidrosis—Epirubicin—stomach cancer	6.39e-05	0.000489	CcSEcCtD
Losartan—Insomnia—Methotrexate—stomach cancer	6.38e-05	0.000489	CcSEcCtD
Losartan—Chest pain—Doxorubicin—stomach cancer	6.38e-05	0.000488	CcSEcCtD
Losartan—Myalgia—Doxorubicin—stomach cancer	6.38e-05	0.000488	CcSEcCtD
Losartan—Arthralgia—Doxorubicin—stomach cancer	6.38e-05	0.000488	CcSEcCtD
Losartan—Anxiety—Doxorubicin—stomach cancer	6.35e-05	0.000486	CcSEcCtD
Losartan—Paraesthesia—Methotrexate—stomach cancer	6.34e-05	0.000485	CcSEcCtD
Losartan—Discomfort—Doxorubicin—stomach cancer	6.3e-05	0.000482	CcSEcCtD
Losartan—Anorexia—Epirubicin—stomach cancer	6.3e-05	0.000482	CcSEcCtD
Losartan—Dyspnoea—Methotrexate—stomach cancer	6.29e-05	0.000482	CcSEcCtD
Losartan—Somnolence—Methotrexate—stomach cancer	6.28e-05	0.00048	CcSEcCtD
Losartan—Dizziness—Capecitabine—stomach cancer	6.27e-05	0.00048	CcSEcCtD
Losartan—Dry mouth—Doxorubicin—stomach cancer	6.24e-05	0.000477	CcSEcCtD
Losartan—Vomiting—Docetaxel—stomach cancer	6.23e-05	0.000477	CcSEcCtD
Losartan—Dyspepsia—Methotrexate—stomach cancer	6.21e-05	0.000475	CcSEcCtD
Losartan—Rash—Docetaxel—stomach cancer	6.18e-05	0.000473	CcSEcCtD
Losartan—Hypotension—Epirubicin—stomach cancer	6.17e-05	0.000472	CcSEcCtD
Losartan—Dermatitis—Docetaxel—stomach cancer	6.17e-05	0.000472	CcSEcCtD
Losartan—Confusional state—Doxorubicin—stomach cancer	6.16e-05	0.000472	CcSEcCtD
Losartan—Decreased appetite—Methotrexate—stomach cancer	6.14e-05	0.00047	CcSEcCtD
Losartan—Headache—Docetaxel—stomach cancer	6.14e-05	0.00047	CcSEcCtD
Losartan—Oedema—Doxorubicin—stomach cancer	6.11e-05	0.000468	CcSEcCtD
Losartan—Anaphylactic shock—Doxorubicin—stomach cancer	6.11e-05	0.000468	CcSEcCtD
Losartan—Fatigue—Methotrexate—stomach cancer	6.09e-05	0.000466	CcSEcCtD
Losartan—Infection—Doxorubicin—stomach cancer	6.07e-05	0.000465	CcSEcCtD
Losartan—Pain—Methotrexate—stomach cancer	6.04e-05	0.000462	CcSEcCtD
Losartan—Vomiting—Capecitabine—stomach cancer	6.03e-05	0.000461	CcSEcCtD
Losartan—Musculoskeletal discomfort—Epirubicin—stomach cancer	6.02e-05	0.000461	CcSEcCtD
Losartan—Shock—Doxorubicin—stomach cancer	6.01e-05	0.00046	CcSEcCtD
Losartan—Nervous system disorder—Doxorubicin—stomach cancer	5.99e-05	0.000459	CcSEcCtD
Losartan—Thrombocytopenia—Doxorubicin—stomach cancer	5.98e-05	0.000458	CcSEcCtD
Losartan—Rash—Capecitabine—stomach cancer	5.98e-05	0.000458	CcSEcCtD
Losartan—Insomnia—Epirubicin—stomach cancer	5.97e-05	0.000457	CcSEcCtD
Losartan—Dermatitis—Capecitabine—stomach cancer	5.97e-05	0.000457	CcSEcCtD
Losartan—Tachycardia—Doxorubicin—stomach cancer	5.97e-05	0.000456	CcSEcCtD
Losartan—Headache—Capecitabine—stomach cancer	5.94e-05	0.000455	CcSEcCtD
Losartan—Paraesthesia—Epirubicin—stomach cancer	5.93e-05	0.000454	CcSEcCtD
Losartan—Hyperhidrosis—Doxorubicin—stomach cancer	5.91e-05	0.000452	CcSEcCtD
Losartan—Dyspnoea—Epirubicin—stomach cancer	5.89e-05	0.000451	CcSEcCtD
Losartan—Somnolence—Epirubicin—stomach cancer	5.87e-05	0.000449	CcSEcCtD
Losartan—Anorexia—Doxorubicin—stomach cancer	5.83e-05	0.000446	CcSEcCtD
Losartan—Nausea—Docetaxel—stomach cancer	5.82e-05	0.000445	CcSEcCtD
Losartan—Feeling abnormal—Methotrexate—stomach cancer	5.82e-05	0.000445	CcSEcCtD
Losartan—Dyspepsia—Epirubicin—stomach cancer	5.82e-05	0.000445	CcSEcCtD
Losartan—Gastrointestinal pain—Methotrexate—stomach cancer	5.77e-05	0.000442	CcSEcCtD
Losartan—Decreased appetite—Epirubicin—stomach cancer	5.74e-05	0.000439	CcSEcCtD
Losartan—Hypotension—Doxorubicin—stomach cancer	5.71e-05	0.000437	CcSEcCtD
Losartan—Fatigue—Epirubicin—stomach cancer	5.7e-05	0.000436	CcSEcCtD
Losartan—Pain—Epirubicin—stomach cancer	5.65e-05	0.000432	CcSEcCtD
Losartan—Constipation—Epirubicin—stomach cancer	5.65e-05	0.000432	CcSEcCtD
Losartan—Nausea—Capecitabine—stomach cancer	5.63e-05	0.000431	CcSEcCtD
Losartan—Urticaria—Methotrexate—stomach cancer	5.61e-05	0.000429	CcSEcCtD
Losartan—Abdominal pain—Methotrexate—stomach cancer	5.58e-05	0.000427	CcSEcCtD
Losartan—Body temperature increased—Methotrexate—stomach cancer	5.58e-05	0.000427	CcSEcCtD
Losartan—Musculoskeletal discomfort—Doxorubicin—stomach cancer	5.57e-05	0.000426	CcSEcCtD
Losartan—Insomnia—Doxorubicin—stomach cancer	5.53e-05	0.000423	CcSEcCtD
Losartan—Paraesthesia—Doxorubicin—stomach cancer	5.49e-05	0.00042	CcSEcCtD
Losartan—Dyspnoea—Doxorubicin—stomach cancer	5.45e-05	0.000417	CcSEcCtD
Losartan—Feeling abnormal—Epirubicin—stomach cancer	5.44e-05	0.000417	CcSEcCtD
Losartan—Somnolence—Doxorubicin—stomach cancer	5.43e-05	0.000416	CcSEcCtD
Losartan—Gastrointestinal pain—Epirubicin—stomach cancer	5.4e-05	0.000413	CcSEcCtD
Losartan—Dyspepsia—Doxorubicin—stomach cancer	5.38e-05	0.000412	CcSEcCtD
Losartan—Decreased appetite—Doxorubicin—stomach cancer	5.31e-05	0.000407	CcSEcCtD
Losartan—Fatigue—Doxorubicin—stomach cancer	5.27e-05	0.000403	CcSEcCtD
Losartan—Urticaria—Epirubicin—stomach cancer	5.25e-05	0.000402	CcSEcCtD
Losartan—Pain—Doxorubicin—stomach cancer	5.23e-05	0.0004	CcSEcCtD
Losartan—Constipation—Doxorubicin—stomach cancer	5.23e-05	0.0004	CcSEcCtD
Losartan—Body temperature increased—Epirubicin—stomach cancer	5.22e-05	0.0004	CcSEcCtD
Losartan—Abdominal pain—Epirubicin—stomach cancer	5.22e-05	0.0004	CcSEcCtD
Losartan—Hypersensitivity—Methotrexate—stomach cancer	5.2e-05	0.000398	CcSEcCtD
Losartan—Asthenia—Methotrexate—stomach cancer	5.06e-05	0.000388	CcSEcCtD
Losartan—Feeling abnormal—Doxorubicin—stomach cancer	5.04e-05	0.000385	CcSEcCtD
Losartan—Gastrointestinal pain—Doxorubicin—stomach cancer	5e-05	0.000382	CcSEcCtD
Losartan—Pruritus—Methotrexate—stomach cancer	4.99e-05	0.000382	CcSEcCtD
Losartan—Hypersensitivity—Epirubicin—stomach cancer	4.87e-05	0.000372	CcSEcCtD
Losartan—Urticaria—Doxorubicin—stomach cancer	4.86e-05	0.000372	CcSEcCtD
Losartan—Abdominal pain—Doxorubicin—stomach cancer	4.83e-05	0.00037	CcSEcCtD
Losartan—Body temperature increased—Doxorubicin—stomach cancer	4.83e-05	0.00037	CcSEcCtD
Losartan—Diarrhoea—Methotrexate—stomach cancer	4.83e-05	0.00037	CcSEcCtD
Losartan—Asthenia—Epirubicin—stomach cancer	4.74e-05	0.000363	CcSEcCtD
Losartan—Pruritus—Epirubicin—stomach cancer	4.67e-05	0.000358	CcSEcCtD
Losartan—Dizziness—Methotrexate—stomach cancer	4.67e-05	0.000357	CcSEcCtD
Losartan—Diarrhoea—Epirubicin—stomach cancer	4.52e-05	0.000346	CcSEcCtD
Losartan—Hypersensitivity—Doxorubicin—stomach cancer	4.5e-05	0.000345	CcSEcCtD
Losartan—Vomiting—Methotrexate—stomach cancer	4.49e-05	0.000343	CcSEcCtD
Losartan—Rash—Methotrexate—stomach cancer	4.45e-05	0.000341	CcSEcCtD
Losartan—Dermatitis—Methotrexate—stomach cancer	4.45e-05	0.00034	CcSEcCtD
Losartan—Headache—Methotrexate—stomach cancer	4.42e-05	0.000338	CcSEcCtD
Losartan—Asthenia—Doxorubicin—stomach cancer	4.39e-05	0.000336	CcSEcCtD
Losartan—Dizziness—Epirubicin—stomach cancer	4.37e-05	0.000334	CcSEcCtD
Losartan—Pruritus—Doxorubicin—stomach cancer	4.32e-05	0.000331	CcSEcCtD
Losartan—Vomiting—Epirubicin—stomach cancer	4.2e-05	0.000321	CcSEcCtD
Losartan—Nausea—Methotrexate—stomach cancer	4.19e-05	0.000321	CcSEcCtD
Losartan—Diarrhoea—Doxorubicin—stomach cancer	4.18e-05	0.00032	CcSEcCtD
Losartan—Rash—Epirubicin—stomach cancer	4.17e-05	0.000319	CcSEcCtD
Losartan—Dermatitis—Epirubicin—stomach cancer	4.16e-05	0.000318	CcSEcCtD
Losartan—Headache—Epirubicin—stomach cancer	4.14e-05	0.000317	CcSEcCtD
Losartan—Dizziness—Doxorubicin—stomach cancer	4.04e-05	0.000309	CcSEcCtD
Losartan—Nausea—Epirubicin—stomach cancer	3.92e-05	0.0003	CcSEcCtD
Losartan—Vomiting—Doxorubicin—stomach cancer	3.89e-05	0.000297	CcSEcCtD
Losartan—Rash—Doxorubicin—stomach cancer	3.85e-05	0.000295	CcSEcCtD
Losartan—Dermatitis—Doxorubicin—stomach cancer	3.85e-05	0.000295	CcSEcCtD
Losartan—Headache—Doxorubicin—stomach cancer	3.83e-05	0.000293	CcSEcCtD
Losartan—Nausea—Doxorubicin—stomach cancer	3.63e-05	0.000278	CcSEcCtD
Losartan—CYP1A2—Metabolism—TYMP—stomach cancer	5.91e-06	7.97e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—FADS1—stomach cancer	5.91e-06	7.97e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP2A6—stomach cancer	5.89e-06	7.94e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTGS2—stomach cancer	5.88e-06	7.93e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CAV1—stomach cancer	5.88e-06	7.92e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—DPYD—stomach cancer	5.87e-06	7.92e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RHOA—stomach cancer	5.87e-06	7.91e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—APOA1—stomach cancer	5.87e-06	7.91e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP2A6—stomach cancer	5.86e-06	7.9e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CA2—stomach cancer	5.86e-06	7.9e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—MTHFR—stomach cancer	5.84e-06	7.87e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NOS3—stomach cancer	5.81e-06	7.83e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—RHOA—stomach cancer	5.8e-06	7.82e-05	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	5.74e-06	7.74e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—NOS3—stomach cancer	5.74e-06	7.74e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKR1C3—stomach cancer	5.73e-06	7.73e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CD44—stomach cancer	5.72e-06	7.71e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ALB—stomach cancer	5.72e-06	7.71e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PGAM1—stomach cancer	5.71e-06	7.69e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NT5E—stomach cancer	5.71e-06	7.69e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—AKR1C3—stomach cancer	5.7e-06	7.68e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	5.66e-06	7.63e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	5.64e-06	7.61e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ENO1—stomach cancer	5.59e-06	7.53e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ALOX5—stomach cancer	5.58e-06	7.52e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—ENO1—stomach cancer	5.55e-06	7.49e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTGS2—stomach cancer	5.54e-06	7.47e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SREBF2—stomach cancer	5.54e-06	7.46e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—PIK3CA—stomach cancer	5.53e-06	7.46e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.49e-06	7.41e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—DPYD—stomach cancer	5.49e-06	7.4e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—RORA—stomach cancer	5.47e-06	7.37e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—NOS3—stomach cancer	5.47e-06	7.37e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.45e-06	7.35e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALDH7A1—stomach cancer	5.45e-06	7.34e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PLCE1—stomach cancer	5.45e-06	7.34e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ERBB2—stomach cancer	5.43e-06	7.32e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CAV1—stomach cancer	5.39e-06	7.26e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—APOA1—stomach cancer	5.37e-06	7.24e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTT1—stomach cancer	5.32e-06	7.17e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP2A6—stomach cancer	5.26e-06	7.09e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—UMPS—stomach cancer	5.22e-06	7.04e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTT1—stomach cancer	5.19e-06	7e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PPARG—stomach cancer	5.17e-06	6.97e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCL8—stomach cancer	5.15e-06	6.95e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.15e-06	6.94e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP2A6—stomach cancer	5.13e-06	6.92e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALDOB—stomach cancer	5.13e-06	6.91e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HRAS—stomach cancer	5.12e-06	6.9e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKR1C3—stomach cancer	5.12e-06	6.9e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CDKN1B—stomach cancer	5.03e-06	6.78e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTGS2—stomach cancer	5e-06	6.74e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKR1C3—stomach cancer	4.99e-06	6.73e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ENO1—stomach cancer	4.99e-06	6.72e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.97e-06	6.7e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CD44—stomach cancer	4.95e-06	6.68e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CD44—stomach cancer	4.93e-06	6.64e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.9e-06	6.61e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL6—stomach cancer	4.9e-06	6.61e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ENO1—stomach cancer	4.87e-06	6.56e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPP2R1A—stomach cancer	4.86e-06	6.56e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PDHA1—stomach cancer	4.85e-06	6.54e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ECHS1—stomach cancer	4.85e-06	6.54e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTT1—stomach cancer	4.85e-06	6.54e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.83e-06	6.52e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.82e-06	6.5e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.81e-06	6.48e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCND1—stomach cancer	4.8e-06	6.47e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP2A6—stomach cancer	4.8e-06	6.46e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—JUN—stomach cancer	4.79e-06	6.46e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.78e-06	6.44e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GSTP1—stomach cancer	4.77e-06	6.43e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALOX5—stomach cancer	4.77e-06	6.42e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PPARG—stomach cancer	4.74e-06	6.38e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—HMOX1—stomach cancer	4.7e-06	6.34e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—DPYD—stomach cancer	4.69e-06	6.32e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKR1C3—stomach cancer	4.67e-06	6.29e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MMP9—stomach cancer	4.66e-06	6.28e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ALB—stomach cancer	4.65e-06	6.26e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CDKN1A—stomach cancer	4.64e-06	6.26e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—FADS1—stomach cancer	4.56e-06	6.15e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TYMP—stomach cancer	4.56e-06	6.15e-05	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	4.55e-06	6.14e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ENO1—stomach cancer	4.55e-06	6.13e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK8—stomach cancer	4.53e-06	6.11e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.47e-06	6.03e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—NOS3—stomach cancer	4.44e-06	5.99e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—TYMS—stomach cancer	4.44e-06	5.98e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CD44—stomach cancer	4.42e-06	5.96e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GSTM1—stomach cancer	4.38e-06	5.91e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CD44—stomach cancer	4.32e-06	5.82e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.29e-06	5.78e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SREBF2—stomach cancer	4.27e-06	5.76e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ALB—stomach cancer	4.26e-06	5.74e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.25e-06	5.73e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—RORA—stomach cancer	4.22e-06	5.69e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPP2R1A—stomach cancer	4.21e-06	5.68e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PPP2R1A—stomach cancer	4.19e-06	5.65e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—stomach cancer	4.19e-06	5.64e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTT1—stomach cancer	4.15e-06	5.59e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—STAT3—stomach cancer	4.14e-06	5.59e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—stomach cancer	4.14e-06	5.57e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTP1—stomach cancer	4.13e-06	5.57e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ERCC2—stomach cancer	4.12e-06	5.56e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTP1—stomach cancer	4.11e-06	5.54e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP2A6—stomach cancer	4.1e-06	5.52e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—HMOX1—stomach cancer	4.08e-06	5.49e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—NOS3—stomach cancer	4.07e-06	5.49e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTGS2—stomach cancer	4.07e-06	5.48e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—HMOX1—stomach cancer	4.05e-06	5.46e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CD44—stomach cancer	4.03e-06	5.44e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKR1C3—stomach cancer	3.99e-06	5.37e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK3—stomach cancer	3.96e-06	5.34e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALDOB—stomach cancer	3.96e-06	5.33e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.91e-06	5.27e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—MAPK3—stomach cancer	3.91e-06	5.27e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ENO1—stomach cancer	3.88e-06	5.24e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—MTHFR—stomach cancer	3.87e-06	5.22e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MYC—stomach cancer	3.85e-06	5.19e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—TYMS—stomach cancer	3.84e-06	5.18e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.82e-06	5.15e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—TYMS—stomach cancer	3.82e-06	5.15e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTM1—stomach cancer	3.8e-06	5.12e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTM1—stomach cancer	3.78e-06	5.09e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK1—stomach cancer	3.77e-06	5.08e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EGFR—stomach cancer	3.77e-06	5.08e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPP2R1A—stomach cancer	3.76e-06	5.07e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTGS2—stomach cancer	3.73e-06	5.02e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—MAPK1—stomach cancer	3.72e-06	5.02e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTP1—stomach cancer	3.69e-06	4.97e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALOX5—stomach cancer	3.68e-06	4.96e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPP2R1A—stomach cancer	3.67e-06	4.95e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—HMOX1—stomach cancer	3.64e-06	4.9e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3CA—stomach cancer	3.62e-06	4.88e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—DPYD—stomach cancer	3.62e-06	4.88e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTP1—stomach cancer	3.6e-06	4.85e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CAV1—stomach cancer	3.57e-06	4.82e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ERCC2—stomach cancer	3.57e-06	4.81e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—APOA1—stomach cancer	3.57e-06	4.81e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KRAS—stomach cancer	3.56e-06	4.8e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—HMOX1—stomach cancer	3.55e-06	4.79e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—ERCC2—stomach cancer	3.55e-06	4.78e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—KRAS—stomach cancer	3.52e-06	4.74e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CD44—stomach cancer	3.45e-06	4.64e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—TYMS—stomach cancer	3.43e-06	4.62e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPP2R1A—stomach cancer	3.43e-06	4.62e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CA—stomach cancer	3.41e-06	4.6e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTM1—stomach cancer	3.39e-06	4.57e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTP1—stomach cancer	3.36e-06	4.53e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—MTHFR—stomach cancer	3.36e-06	4.52e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—TYMS—stomach cancer	3.35e-06	4.51e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.34e-06	4.51e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—MTHFR—stomach cancer	3.34e-06	4.5e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—HMOX1—stomach cancer	3.32e-06	4.47e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTM1—stomach cancer	3.31e-06	4.46e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CA—stomach cancer	3.27e-06	4.41e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CA—stomach cancer	3.23e-06	4.35e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTT1—stomach cancer	3.2e-06	4.31e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ERCC2—stomach cancer	3.19e-06	4.3e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP2A6—stomach cancer	3.16e-06	4.26e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—stomach cancer	3.16e-06	4.26e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPARG—stomach cancer	3.14e-06	4.23e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—TYMS—stomach cancer	3.13e-06	4.21e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—stomach cancer	3.12e-06	4.21e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ERCC2—stomach cancer	3.11e-06	4.19e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CAV1—stomach cancer	3.1e-06	4.17e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTM1—stomach cancer	3.09e-06	4.17e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—APOA1—stomach cancer	3.09e-06	4.16e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CA—stomach cancer	3.08e-06	4.15e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CAV1—stomach cancer	3.08e-06	4.15e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKR1C3—stomach cancer	3.08e-06	4.15e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—APOA1—stomach cancer	3.07e-06	4.14e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HRAS—stomach cancer	3.02e-06	4.08e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ENO1—stomach cancer	3e-06	4.04e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—MTHFR—stomach cancer	3e-06	4.04e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—HRAS—stomach cancer	2.99e-06	4.03e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.96e-06	3.99e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.94e-06	3.96e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPP2R1A—stomach cancer	2.93e-06	3.95e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—MTHFR—stomach cancer	2.92e-06	3.94e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ERCC2—stomach cancer	2.91e-06	3.92e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6—stomach cancer	2.89e-06	3.9e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTP1—stomach cancer	2.87e-06	3.87e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—HMOX1—stomach cancer	2.83e-06	3.82e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ALB—stomach cancer	2.82e-06	3.81e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CAV1—stomach cancer	2.76e-06	3.72e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—APOA1—stomach cancer	2.76e-06	3.72e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—MTHFR—stomach cancer	2.73e-06	3.68e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPARG—stomach cancer	2.72e-06	3.67e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PPARG—stomach cancer	2.71e-06	3.65e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—NOS3—stomach cancer	2.7e-06	3.64e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CAV1—stomach cancer	2.7e-06	3.64e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—APOA1—stomach cancer	2.69e-06	3.63e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TYMS—stomach cancer	2.67e-06	3.6e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CD44—stomach cancer	2.66e-06	3.58e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTM1—stomach cancer	2.64e-06	3.56e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.64e-06	3.56e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CAV1—stomach cancer	2.52e-06	3.4e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—APOA1—stomach cancer	2.51e-06	3.39e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CA—stomach cancer	2.5e-06	3.37e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ERCC2—stomach cancer	2.48e-06	3.35e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGS2—stomach cancer	2.47e-06	3.33e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ALB—stomach cancer	2.45e-06	3.3e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPARG—stomach cancer	2.43e-06	3.27e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.41e-06	3.24e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPARG—stomach cancer	2.37e-06	3.2e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—NOS3—stomach cancer	2.34e-06	3.15e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—MTHFR—stomach cancer	2.33e-06	3.15e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—NOS3—stomach cancer	2.33e-06	3.14e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CA—stomach cancer	2.29e-06	3.09e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.26e-06	3.05e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTP1—stomach cancer	2.22e-06	2.99e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPARG—stomach cancer	2.21e-06	2.99e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HMOX1—stomach cancer	2.19e-06	2.95e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ALB—stomach cancer	2.18e-06	2.94e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CAV1—stomach cancer	2.15e-06	2.9e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—APOA1—stomach cancer	2.15e-06	2.9e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGS2—stomach cancer	2.14e-06	2.89e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ALB—stomach cancer	2.13e-06	2.87e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGS2—stomach cancer	2.13e-06	2.87e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—NOS3—stomach cancer	2.09e-06	2.82e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TYMS—stomach cancer	2.06e-06	2.78e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.06e-06	2.77e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—NOS3—stomach cancer	2.04e-06	2.75e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTM1—stomach cancer	2.04e-06	2.75e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ALB—stomach cancer	1.99e-06	2.68e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ERCC2—stomach cancer	1.92e-06	2.58e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGS2—stomach cancer	1.91e-06	2.58e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NOS3—stomach cancer	1.9e-06	2.57e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPARG—stomach cancer	1.89e-06	2.55e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGS2—stomach cancer	1.86e-06	2.51e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—MTHFR—stomach cancer	1.8e-06	2.43e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGS2—stomach cancer	1.74e-06	2.35e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALB—stomach cancer	1.7e-06	2.29e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CAV1—stomach cancer	1.66e-06	2.24e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APOA1—stomach cancer	1.66e-06	2.23e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NOS3—stomach cancer	1.63e-06	2.19e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CA—stomach cancer	1.52e-06	2.05e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGS2—stomach cancer	1.49e-06	2.01e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPARG—stomach cancer	1.46e-06	1.97e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CA—stomach cancer	1.32e-06	1.78e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALB—stomach cancer	1.31e-06	1.77e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CA—stomach cancer	1.31e-06	1.77e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NOS3—stomach cancer	1.26e-06	1.69e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.18e-06	1.58e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGS2—stomach cancer	1.15e-06	1.55e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CA—stomach cancer	1.15e-06	1.55e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.07e-06	1.44e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CA—stomach cancer	9.16e-07	1.23e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CA—stomach cancer	7.07e-07	9.53e-06	CbGpPWpGaD
